Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study

Renato Quispe1,2, Seth Shay Martin1,2, Erin Donelly Michos1,2

  • 1Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Baltimore, MD, USA.

Insights

Remnant cholesterol (RC) increases atherosclerotic cardiovascular disease (ASCVD) risk, even beyond LDL-C and apoB. Elevated RC is linked to ASCVD in individuals without prior ASCVD, suggesting a need for further investigation into its role in primary prevention.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Preventive Cardiology

Background:

  • Emerging evidence implicates remnant cholesterol (RC) in promoting atherosclerotic cardiovascular disease (ASCVD).
  • Traditional lipid markers like low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B (apoB) are established ASCVD risk factors.
  • The independent contribution of RC to ASCVD risk in individuals without diagnosed ASCVD requires further elucidation.

Purpose of the Study:

  • To quantify the risk of incident ASCVD associated with remnant cholesterol (RC) levels.
  • To determine if RC confers additional risk beyond established markers like LDL-C and apoB in an ASCVD-free population.
  • To explore discordant risk profiles, specifically high RC with low LDL-C, and their association with ASCVD.

Main Methods:

  • Pooled data from 17,532 individuals across three large cohort studies (ARIC, MESA, YOUTH).
  • Remnant cholesterol calculated as non-HDL-C minus calculated LDL-C.
  • Adjusted Cox proportional hazards models and discordance analyses were employed to assess ASCVD risk.

Main Results:

  • After multivariable adjustment including LDL-C and apoB, elevated log RC levels were significantly associated with increased ASCVD risk (HR 1.65, 95% CI 1.45-1.89).
  • Individuals with high RC and low LDL-C demonstrated increased ASCVD risk compared to a concordant group (HR 1.21, 95% CI 1.08-1.34).
  • This association persisted even when discordance was evaluated against clinical LDL-C targets.

Conclusions:

  • Elevated remnant cholesterol (RC) is an independent predictor of ASCVD in individuals without prior ASCVD, beyond traditional risk factors, LDL-C, and apoB.
  • The findings suggest RC may play a significant role in ASCVD pathogenesis, potentially through mechanisms not fully captured by apoB.
  • Further research is warranted to investigate the biological mechanisms underlying RC's association with ASCVD and its potential utility in primary prevention strategies.
Abstract

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
847
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
425
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
82
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
364
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.3K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
267